Symbiotiq Invest Holding ApS: Financial statements 2024
CVR: 43719335
Symbiotiq Invest Holding ApS (CVR 43719335) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -1,030 and a net result of DKK -785 compared with DKK -6,857 the year before. Equity amounted to DKK 32,358. The solvency ratio was 88.2%.
- Gross Profit
- -1,030 kr.
- Profit/Loss
- -785 kr.
- Equity
- 32,358 kr.
- Total Assets
- 36,703 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -1 t. | -785 | 32 t. | - |
| 2023 | - | -4 t. | -7 t. | 33 t. | - |
How creditworthy is Symbiotiq Invest Holding ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
Symbiotiq Invest Holding ApS has published its annual report for 2023. Gross profit came to DKK -4,250, and the net result was DKK -6,857.
About Symbiotiq Invest Holding ApS
Symbiotiq Invest Holding ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2022. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Mads Bonde. The company is owned by Symbiotiq ApS. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -300 compared with DKK -785 the year before. Equity amounted to DKK 32,058.
